Adalimumab Clinical Trials
25 recruitingDrug
Phase 210Phase 48Phase 33Phase 11Not Applicable1
Showing 1–20 of 25 trials
Recruiting
Phase 2
An Exploratory Study of the Potential for Rational Immune System Manipulation to Prevent Emergence of Synucleinopathy Manifestations in Persons With REM Sleep Behavior Disorder (RBD)
REM Sleep Behavior Disorder
Yale University108 enrolled20 locationsNCT06996652
Recruiting
Phase 4
A Study of Vedolizumab Intravenous (IV) and Adalimumab or Vedolizumab and Ustekinumab in Adults With Crohn's Disease
Crohn's Disease
Takeda100 enrolled53 locationsNCT06045754
Recruiting
Phase 2
Immunosuppressant Management in Rheumatology Patients Undergoing Elective Total Shoulder Arthroplasty
Rheumatic disease
NYU Langone Health80 enrolled1 locationNCT07138898
Recruiting
Comparison of the Efficacy of Different Biologic Agents in Preventing Postoperative Endoscopic Recurrence of Crohn's Disease
Crohn Disease (CD)Inflamatory Bowel Disease
Shanghai 10th People's Hospital198 enrolled1 locationNCT07694674
Recruiting
Phase 3
A Study to Assess Adverse Events, Change in Disease Activity, and How the Drug Moves Through the Body in Children With Juvenile Psoriatic Arthritis (jPsA) Receiving Subcutaneously Injected Risankizumab or Adalimumab
Juvenile Psoriatic Arthritis
AbbVie40 enrolled33 locationsNCT06100744
Recruiting
Phase 3
Treatment of Rheumatoid Arthritis With DMARDs: Predictors of Response
Rheumatoid Arthritis
University of Nebraska400 enrolled1 locationNCT03414502
Recruiting
Phase 1Phase 2
A Randomized Phase 1/2 Trial of Low Dose Anti-thymocyte Globulin (ATG) With Subsequent Adalimumab or Verapamil in New Onset Type 1 Diabetes
Type 1 DiabetesNew Onset
City of Hope Medical Center120 enrolled11 locationsNCT07061574
Recruiting
Phase 2
A Study of LAD191 in Adults With Hidradenitis Suppurativa
Hidradenitis Suppurativa
Almirall, S.A.200 enrolled1 locationNCT07151937
Recruiting
Phase 4
Comparison of Vedolizumab Treatment to Adalimumab Dose Intensification in Crohn's Disease Patients With Loss of Response or Biomarker Activity to Adalimumab on First Line With Therapeutic Drug Concentration.
Crohn's Disease
Centre Hospitalier Universitaire de Saint Etienne220 enrolled12 locationsNCT06180382
Recruiting
Not Applicable
Biologic Treatment Withdrawal in Takayasu Arteritis Patients in Sustained Remission
Takayasu Arteritis
Marmara University40 enrolled1 locationNCT07491913
Recruiting
Phase 2
Early Adalimumab Induction for Immune Checkpoint Inhibitor Associated Inflammatory Arthritis
Immune-related Adverse EventInflammatory Arthritis
Tom Appleton30 enrolled1 locationNCT06037811
Recruiting
Phase 2
An Open-Label Study of Effectiveness of Immunomodulatory Medications for Patients With Relapsing Polychondritis
Relapsing Polychondritis
University of Pennsylvania20 enrolled1 locationNCT06941376
Recruiting
Phase 2Phase 3
Using a Contact Dermatitis Model With Biologic Medications to Study Skin Inflammation
Skin InflammationAllergic Contact Dermatitis
Wei-Che Ko45 enrolled1 locationNCT05535738
Recruiting
Phase 2
Intravitreal Adalimumab Versus Subcutaneous Adalimumab in Non-infectious Uveitis
UveitisNon Infectious Uveitis
American University of Beirut Medical Center32 enrolled1 locationNCT02706704
Recruiting
Phase 2
Baricitinib in the Treatment of Intestinal Behçet's Syndrome
Behcet Syndrome, Intestinal Type
Peking Union Medical College Hospital56 enrolled2 locationsNCT06849908
Recruiting
Swiss Dermatology Network of Targeted Therapies (SDNTT)
Psoriasis
Swiss Dermatology Network for Targeted Therapies1,121 enrolled6 locationsNCT01706692
Recruiting
Phase 2
Effects of TNF Blockade on Human BPH/LUTS
Benign Prostatic Hyperplasia (BPH)
Endeavor Health70 enrolled1 locationNCT06062875
Recruiting
Phase 4
A Randomized, Controlled, Open-label, Multicenter Clinical Trial Comparing the Efficacy and Safety of a Precision Treatment Regimen Based on Clinical-molecular Phenotypes with a Conventional Treatment Regimen in the Treatment of Patients with Active Takayasu's Arteritis
Takayasu Arteritis
Shanghai Zhongshan Hospital124 enrolled1 locationNCT06498089
Recruiting
Phase 4
Filgotinib Effect on Proteomic Profile and Micro-RNA Expression in Patients With Active Rheumatoid Arthritis (RA)
Rheumatoid Arthritis
Universita di Verona30 enrolled1 locationNCT06527534
Recruiting
CHronic Nonbacterial Osteomyelitis International Registry
Chronic Recurrent Multifocal OsteomyelitisChronic Nonbacterial Osteomyelitis
Seattle Children's Hospital2,000 enrolled1 locationNCT04725422